Telomerase activity, and tissue polypeptide specific antigen (TPS) in Egyptian breast cancer patients.
暂无分享,去创建一个
[1] P. Drew,et al. Genetic changes associated with telomerase activity in breast cancer , 1999, International journal of cancer.
[2] R. Wurm,et al. Telomere shortening triggers a p53-dependent cell cycle arrest via accumulation of G-rich single stranded DNA fragments , 1999, Oncogene.
[3] S. Sukumar,et al. Telomerase activity in ductal carcinoma in situ and invasive breast cancer , 1999, Oncogene.
[4] K. Mokbel,et al. Telomerase activity and prognosis in breast cancer. , 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[5] S. Sukumar,et al. Applications of telomerase research in the fight against cancer. , 1999, Molecular medicine today.
[6] C. Poremba,et al. Telomerase activity in human proliferative breast lesions. , 1998, International journal of oncology.
[7] B. Pogo,et al. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[8] Z. Kopczyński,et al. The value of tissue polypeptide specific antigen TPS determination in serum of women with breast cancer comparison to mucin-like associated antigen MCA and CA 15-3 antigen. , 1998, European journal of gynaecological oncology.
[9] C. Osborne,et al. Telomerase activity and survival of patients with node-positive breast cancer. , 1997, Journal of the National Cancer Institute.
[10] E. Blackburn. The telomere and telomerase: nucleic acid-protein complexes acting in a telomere homeostasis system. A review. , 1997, Biochemistry. Biokhimiia.
[11] Nam W. Kim,et al. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP) , 1997, Nucleic Acids Res..
[12] J. Shay,et al. A survey of telomerase activity in human cancer. , 1997, European journal of cancer.
[13] E. K. Parkinson,et al. Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer , 1997, Oncogene.
[14] J. T. Lumeij,et al. Avian Clinical Biochemistry , 1997 .
[15] F. Ishikawa. [Telomere and telomerase]. , 1996, Human Cell.
[16] G. Eklund,et al. Notable relationship between the level of tumor marker TPS in serum and survival in breast cancer. , 1996, Anticancer research.
[17] J. Shay,et al. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. , 1995, Nucleic acids research.
[18] T. Salman,et al. The clinical value of serum TPS in gynecological malignancies , 1995, The International journal of biological markers.
[19] C B Harley,et al. Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.
[20] Henderson Ar,et al. Assessing test accuracy and its clinical consequences: a primer for receiver operating characteristic curve analysis. , 1993 .
[21] Max H. Myers,et al. Manual for Staging of Cancer , 1992 .
[22] C B Harley,et al. Telomere loss: mitotic clock or genetic time bomb? , 1991, Mutation research.
[23] I. MartínezMartínez. Epidemiology of Cancer , 1984 .
[24] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.